No insider purchase over the last 90 days. The latest was filed 05 Aug 2024.
Every trade that managers of Destiny Pharma plc disclose to RNS (LSE) is tracked on this page. Destiny Pharma plc has had no insider filing for more than a year; the last one goes back to 5 August 2024.
Since 2023, the database holds 2 purchases and no sales by insiders of the company.
For comparison within the same market, see the insider buying recorded at CMC Markets plc. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
4 of 4 declarations
Destiny Pharma plc is a UK-based biopharmaceutical company focused on developing treatments for bacterial infections. It aims to provide innovative solutions to combat antibiotic resistance.
Purchases our model currently ranks for the recommendations list.
All recommendations